Our data suggest that neuroblastoma cells co-treated with JQ1 and anti-microtubule drugs are unable to recover from anti-microtubule drug-mediated cell cycle arrest at the mitotic phase due to JQ1-induced BRD4 inhibition. This evidence concerns the gene BRD4 and neuroblastoma.